All News PreveCeutical Medical Inc.

Equities

CA74141E1043

Market Closed - Canadian Securities Exchange Other stock markets 11:36:48 2024-06-27 EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		0.00%	0.00%

06-28	PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
05-02	PreveCeutical Medical Inc. announced that it expects to receive CAD 0.25 million in funding	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PreveCeutical Provides Update on Management Cease Trade Order	06-28	NE
PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06-28	CI
PreveCeutical Enters into Loan Agreements	06-17	NE
PreveCeutical Provides Update on Management Cease Trade Order	06-14	NE
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence	06-06	NE
Preveceutical Provides Update on Management Cease Trade Order	05-30	NE
Preveceutical Announces First Tranche Closing of Private Placement	05-29	NE
PreveCeutical Medical : Announces First Tranche Closing of Private Placement	05-29	PU
PreveCeutical Provides Update on Management Cease Trade Order	05-16	NE
PreveCeutical Announces Management Cease Trade Order	05-02	NE
PreveCeutical Medical Inc. announced that it expects to receive CAD 0.25 million in funding	05-01	CI
PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	12-04	CI
PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program	12-04	MT
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
PreveCeutical & Endosane Announce Update on Intranasal CBD Application	23-09-18	MT
PreveCeutical Medical Inc. and Endosane Pharmaceuticals GmbH Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD and Pharmacologically Relevant Doses Following Intranasal CBD Application	23-09-18	CI
PreveCeutical Medical Inc. Showcases Dynamic Evolution in AI Strategy	23-09-12	CI
PreveCeutical Medical : Showcases Dynamic Evolution in AI Strategy	23-09-12	PU
PreveCeutical Engages New to the Street for Production and Broadcasting Services	23-09-01	AQ
PreveCeutical Medical : Engages New to the Street for Production & Broadcasting Services	23-08-31	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News PreveCeutical Medical Inc.

Equities

PREV

CA74141E1043

All News

Filters